arrow
R

Rie Baba

University of Tokyo
H指数:17
被引数:2,680

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long COVID among the first three waves of COVID-19 in Japan: a multicentre cohort study
2024-12-250
OAAI
Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task Force
2023-06-083
OAAI
Annexin A1 is a cell-intrinsic metalloregulator of zinc in human ILC2s
2023-06-016
OA
Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity

单细胞分析和宿主遗传学强调先天免疫细胞在新型冠状病毒肺炎严重程度中的作用

2023-04-2418
OAAI
Multi-omics of NET formation and correlations with CNDP1, PSPB, and L-cystine levels in severe and mild COVID-19 infections

严重和轻度新型冠状病毒肺炎感染中NET形成的多组学及其与CNDP1,PSPB和L-胱氨酸水平的相关性

HELIYON
IF3.6
2023-03-011
OAAI
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force
2022-08-2213
OAAI
Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol
2021-11-2613
OAAI
Characterization of a new SARS-CoV-2 variant that emerged in Brazil
2021-06-1756
OAAI
Longitudinal antibody repertoire in mild versus severeCOVID-19 patients reveals immune markers associated with disease severity and resolution
2021-03-0555
OAAI
Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
2021-02-01114
OAAI
Comparison of Rapid Antigen Tests for COVID-19
2020-12-10173
OAAI
Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia
2012-10-0168
PREAI
Intramuscular Transplantation of G-CSF-Mobilized CD34+ Cells in Patients With Critical Limb Ischemia: A Phase I/IIa, Multicenter, Single-Blinded, Dose-Escalation Clinical Trial

在严重肢体缺血患者中肌内移植g-csf动员的CD34细胞: I/IIa期,多中心,单盲,剂量递增临床试验

2009-08-26206
OAAI